vs

Side-by-side financial comparison of TEAM INC (TISI) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

TEAM INC is the larger business by last-quarter revenue ($224.8M vs $127.1M, roughly 1.8× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 5.4%). TEAM INC produced more free cash flow last quarter ($14.6M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 6.1%).

TeamViewer SE is an international technology company headquartered in Göppingen, Germany. The company became known for the TeamViewer remote access and support software of the same name. Within the TeamViewer software, customers can connect, monitor, and control computers, machines, and other devices. It can be used in various industries, for example, to digitalize processes along the industrial value chain. The company is listed on the stock exchange and is a member of MDAX and TecDAX.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

TISI vs ZLAB — Head-to-Head

Bigger by revenue
TISI
TISI
1.8× larger
TISI
$224.8M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+11.7% gap
ZLAB
17.1%
5.4%
TISI
More free cash flow
TISI
TISI
$41.3M more FCF
TISI
$14.6M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
6.1%
TISI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TISI
TISI
ZLAB
ZLAB
Revenue
$224.8M
$127.1M
Net Profit
$-3.8M
Gross Margin
25.9%
51.0%
Operating Margin
2.9%
-54.6%
Net Margin
-1.7%
Revenue YoY
5.4%
17.1%
Net Profit YoY
47.4%
EPS (diluted)
$-1.46
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TISI
TISI
ZLAB
ZLAB
Q4 25
$224.8M
$127.1M
Q3 25
$225.0M
$115.4M
Q2 25
$248.0M
$109.1M
Q1 25
$198.7M
$105.7M
Q4 24
$213.3M
$108.5M
Q3 24
$210.8M
$101.8M
Q2 24
$228.6M
$100.1M
Q1 24
$199.6M
$87.1M
Net Profit
TISI
TISI
ZLAB
ZLAB
Q4 25
$-3.8M
Q3 25
$-11.4M
$-36.0M
Q2 25
$-4.3M
$-40.7M
Q1 25
$-29.7M
$-48.4M
Q4 24
$-7.2M
Q3 24
$-11.1M
$-41.7M
Q2 24
$-2.8M
$-80.3M
Q1 24
$-17.2M
$-53.5M
Gross Margin
TISI
TISI
ZLAB
ZLAB
Q4 25
25.9%
51.0%
Q3 25
25.8%
59.5%
Q2 25
27.5%
60.6%
Q1 25
23.8%
63.6%
Q4 24
26.9%
61.5%
Q3 24
25.4%
64.1%
Q2 24
27.8%
64.9%
Q1 24
24.4%
61.4%
Operating Margin
TISI
TISI
ZLAB
ZLAB
Q4 25
2.9%
-54.6%
Q3 25
0.6%
-42.3%
Q2 25
4.9%
-50.3%
Q1 25
-3.0%
-53.3%
Q4 24
1.0%
-62.6%
Q3 24
1.5%
-66.6%
Q2 24
4.9%
-76.0%
Q1 24
-3.2%
-80.7%
Net Margin
TISI
TISI
ZLAB
ZLAB
Q4 25
-1.7%
Q3 25
-5.1%
-31.2%
Q2 25
-1.7%
-37.3%
Q1 25
-15.0%
-45.8%
Q4 24
-3.4%
Q3 24
-5.3%
-40.9%
Q2 24
-1.2%
-80.2%
Q1 24
-8.6%
-61.4%
EPS (diluted)
TISI
TISI
ZLAB
ZLAB
Q4 25
$-1.46
$-0.05
Q3 25
$-2.68
$-0.03
Q2 25
$-0.95
$-0.04
Q1 25
$-6.61
$-0.04
Q4 24
$-1.60
$-0.09
Q3 24
$-2.52
$-0.04
Q2 24
$-0.63
$-0.08
Q1 24
$-3.89
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TISI
TISI
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$18.1M
$689.6M
Total DebtLower is stronger
$293.3M
Stockholders' EquityBook value
$-24.5M
$715.5M
Total Assets
$485.5M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TISI
TISI
ZLAB
ZLAB
Q4 25
$18.1M
$689.6M
Q3 25
$14.8M
$717.2M
Q2 25
$20.7M
$732.2M
Q1 25
$16.8M
$757.3M
Q4 24
$35.5M
$779.7M
Q3 24
$19.1M
$616.1M
Q2 24
$22.5M
$630.0M
Q1 24
$24.2M
$650.8M
Total Debt
TISI
TISI
ZLAB
ZLAB
Q4 25
$293.3M
Q3 25
$298.8M
Q2 25
$366.4M
Q1 25
$349.8M
Q4 24
$318.6M
Q3 24
$314.2M
Q2 24
$313.0M
Q1 24
$300.0M
Stockholders' Equity
TISI
TISI
ZLAB
ZLAB
Q4 25
$-24.5M
$715.5M
Q3 25
$-17.7M
$759.9M
Q2 25
$-22.9M
$791.7M
Q1 25
$-26.0M
$810.8M
Q4 24
$1.7M
$840.9M
Q3 24
$17.9M
$667.7M
Q2 24
$23.9M
$704.2M
Q1 24
$26.3M
$762.2M
Total Assets
TISI
TISI
ZLAB
ZLAB
Q4 25
$485.5M
$1.2B
Q3 25
$531.0M
$1.2B
Q2 25
$548.4M
$1.2B
Q1 25
$515.2M
$1.2B
Q4 24
$528.4M
$1.2B
Q3 24
$545.4M
$985.3M
Q2 24
$549.6M
$987.4M
Q1 24
$535.5M
$988.4M
Debt / Equity
TISI
TISI
ZLAB
ZLAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
183.33×
Q3 24
17.55×
Q2 24
13.11×
Q1 24
11.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TISI
TISI
ZLAB
ZLAB
Operating Cash FlowLast quarter
$16.8M
$-26.0M
Free Cash FlowOCF − Capex
$14.6M
$-26.7M
FCF MarginFCF / Revenue
6.5%
-21.0%
Capex IntensityCapex / Revenue
0.9%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.6M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TISI
TISI
ZLAB
ZLAB
Q4 25
$16.8M
$-26.0M
Q3 25
$3.9M
$-32.0M
Q2 25
$-3.3M
$-31.0M
Q1 25
$-28.7M
$-61.7M
Q4 24
$21.6M
$-55.8M
Q3 24
$5.6M
$-26.8M
Q2 24
$-6.4M
$-42.2M
Q1 24
$1.9M
$-90.1M
Free Cash Flow
TISI
TISI
ZLAB
ZLAB
Q4 25
$14.6M
$-26.7M
Q3 25
$1.0M
$-35.0M
Q2 25
$-6.3M
$-33.9M
Q1 25
$-30.1M
$-63.2M
Q4 24
$19.6M
$-58.4M
Q3 24
$3.9M
$-28.2M
Q2 24
$-9.1M
$-42.9M
Q1 24
$-1.1M
$-91.1M
FCF Margin
TISI
TISI
ZLAB
ZLAB
Q4 25
6.5%
-21.0%
Q3 25
0.5%
-30.4%
Q2 25
-2.5%
-31.1%
Q1 25
-15.1%
-59.9%
Q4 24
9.2%
-53.8%
Q3 24
1.9%
-27.7%
Q2 24
-4.0%
-42.9%
Q1 24
-0.6%
-104.5%
Capex Intensity
TISI
TISI
ZLAB
ZLAB
Q4 25
0.9%
0.5%
Q3 25
1.3%
2.6%
Q2 25
1.2%
2.6%
Q1 25
0.7%
1.5%
Q4 24
0.9%
2.4%
Q3 24
0.8%
1.3%
Q2 24
1.2%
0.7%
Q1 24
1.5%
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TISI
TISI

Repairand Maintenance Services$114.8M51%
Non Destructive Evaluation And Testing Services$84.9M38%
Heat Treating$14.2M6%
Other Services$9.3M4%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons